收费全文 | 8430篇 |
免费 | 689篇 |
国内免费 | 45篇 |
耳鼻咽喉 | 29篇 |
儿科学 | 217篇 |
妇产科学 | 190篇 |
基础医学 | 1093篇 |
口腔科学 | 309篇 |
临床医学 | 788篇 |
内科学 | 1355篇 |
皮肤病学 | 140篇 |
神经病学 | 866篇 |
特种医学 | 497篇 |
外科学 | 1083篇 |
综合类 | 219篇 |
一般理论 | 8篇 |
预防医学 | 812篇 |
眼科学 | 65篇 |
药学 | 579篇 |
中国医学 | 4篇 |
肿瘤学 | 910篇 |
2021年 | 98篇 |
2020年 | 65篇 |
2019年 | 112篇 |
2018年 | 122篇 |
2017年 | 111篇 |
2016年 | 130篇 |
2015年 | 124篇 |
2014年 | 200篇 |
2013年 | 269篇 |
2012年 | 392篇 |
2011年 | 416篇 |
2010年 | 240篇 |
2009年 | 217篇 |
2008年 | 391篇 |
2007年 | 374篇 |
2006年 | 360篇 |
2005年 | 351篇 |
2004年 | 378篇 |
2003年 | 339篇 |
2002年 | 306篇 |
2001年 | 265篇 |
2000年 | 280篇 |
1999年 | 260篇 |
1998年 | 138篇 |
1997年 | 126篇 |
1996年 | 108篇 |
1995年 | 101篇 |
1994年 | 122篇 |
1993年 | 82篇 |
1992年 | 225篇 |
1991年 | 199篇 |
1990年 | 164篇 |
1989年 | 174篇 |
1988年 | 145篇 |
1987年 | 169篇 |
1986年 | 157篇 |
1985年 | 145篇 |
1984年 | 95篇 |
1983年 | 100篇 |
1982年 | 60篇 |
1981年 | 76篇 |
1979年 | 75篇 |
1978年 | 78篇 |
1977年 | 56篇 |
1976年 | 60篇 |
1975年 | 55篇 |
1974年 | 64篇 |
1973年 | 51篇 |
1972年 | 56篇 |
1971年 | 59篇 |
Objective
To determine whether differences in combination DTaP vaccine types at 2, 4 and 6?months of age were associated with mortality (all-cause or non-specific), within 30?days of vaccination.Design
Observational nationwide cohort study.Setting
Linked population data from the Australian Childhood Immunisation Register and National Death Index.Participants
Australian infants administered a combination trivalent, quadrivalent or hexavalent DTaP vaccine (DTaP types) between January 1999 and December 2010 at 2, 4 and 6?months as part of the primary vaccination series. The study population included 2.9, 2.6, & 2.3?million children in the 2, 4 and 6?month vaccine cohorts, respectively.Main outcome measures
Infants were evaluated for the primary outcome of all-cause mortality within 30?days. A secondary outcome was non-specific mortality (unknown cause of death) within 30?days of vaccination. Non-specific mortality was defined as underlying or other cause of death codes, R95 ‘Sudden infant death syndrome’, R96 ‘Other sudden death, cause unknown’, R98 ‘Unattended death’, R99 ‘Other ill-defined and unspecified cause of mortality’ or where no cause of death was recorded.Results
The rate of 30?day all-cause mortality was low and declined from 127.4 to 59.3 deaths per 100,000 person-years between 2 and 6?month cohorts. When compared with trivalent DTaP vaccines, no elevated risk in all-cause or non-specific mortality was seen with any quadrivalent or hexavalent DTaP vaccines, for any cohort.Conclusion
Use of routine DTaP combination vaccines with differing disease antigens administered during the first six months of life is not associated with infant mortality. 相似文献Methods: The effects of desflurane on isometric force in guinea pig ventricular papillary muscles were studied in modified standard and in 26 mm K+ Tyrode solution with 0.1 [mu]m isoproterenol. Desflurane effects on sarcoplasmic reticulum Ca2+ release were also determined by examining its actions on rat papillary muscles, guinea pig papillary muscles in low-Na+ Tyrode solution, and rapid cooling contractures. Normal and slow action potentials were recorded using a conventional microelectrode technique. Ca2+ and K+ currents of guinea pig ventricular myocytes were examined.
Results: Desflurane (5.3% and 11.6%) decreased peak force to approximately 70% and 40% of the baseline, respectively, similar to the effects of equianesthetic isoflurane concentrations. With isoproterenol in 26 mm K+ Tyrode solution, desflurane markedly depressed late peaking force and modestly depressed early peak force. The rested state contractions of rat myocardium or guinea pig myocardium in low-Na+ Tyrode solution were modestly depressed, whereas rapid cooling contractures were virtually abolished after desflurane administration. Desflurane significantly prolonged the action potential duration. Desflurane reduced L-type Ca2+ current and the delayed outward K+ current but did not alter the inward rectifier K+ current. 相似文献